Navigation Links
Robin C. Stracey Joins Cantimer, Inc. as President and CEO
Date:12/17/2007

Co-founder Ray Stewart, Ph.D., continues as Chief Technology Officer

MENLO PARK, Calif., Dec. 17 /PRNewswire/ -- Cantimer, Inc., a privately-held development stage company commercializing a patented, proprietary sensor technology platform having applications in life science, health care, bio-defense and consumer markets announced today that Robin C. Stracey has joined the company as President and Chief Executive Officer, effective December 17, 2007. He has also been appointed to the Company's Board of Directors.

Mr. Stracey succeeds Cantimer co-founder Ray Stewart, Ph.D., who will continue to serve as Chief Technology Officer and as a member of the Board of Directors. "Ray has done an exceptional job in developing Cantimer's technology platform and in guiding the company through its early stages," commented A. Wayne Tamarelli, Ph.D., an early investor in Cantimer and a member of its Board of Directors. "He will continue to play the leading technical role as we further develop the platform and explore its application to a number of potentially large opportunities for the rapid detection and measurement of analytes of interest."

"We are delighted to have Robin join us to lead the next phase of the Company's growth as his background and skills are directly aligned with the Company's needs," noted Ray Stewart, Ph.D. "His experience in building and leading successful life science and diagnostics businesses will be invaluable as we move towards the launch of our first commercial product- a non-invasive, point-of-care device for rapid, convenient measurement of human hydration status," added Stewart.

Before joining Cantimer, Mr. Stracey served as Director, President and CEO of Applied Imaging Corporation, a publicly-traded, specialty medical device company focused on the early diagnosis of genetic disorders and cancer. Robin negotiated the successful sale of Applied Imaging to the UK-based Genetix Group plc. in 2006. Prior to that, he was
'/>"/>

SOURCE Cantimer, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Nektar Therapeutics President and CEO Howard Robin to Present at 2007 BIO InvestorForum
2. Roche Joins Forces With Enon Tabernacle Baptist Church to Provide Free Hepatitis C Testing to the Community
3. Ralf Rosskamp, M.D. Joins Biodels Scientific Advisory Board
4. Hank Plain Joins Morgenthaler Ventures as Partner
5. Legendary Earvin Magic Johnson Joins AFL/Signalife Cardiovascular Protection Team
6. Senior Research Analyst Richard Evans Joins AVOS Life Sciences
7. Dan Broderick Joins Prolog Ventures as Partner
8. Ingenuity Systems Joins Biomarkers Consortium
9. Founder of ILEX Oncology and Triton Biosciences, Richard Love, Joins Board of Directors of Cell Therapeutics, Inc. (CTI)
10. Glycominds Joins Biomolecular Photonic (BMP) Consortium to Develop New Molecular Imaging Technique
11. Progeniq Joins Microsoft in Bio IT Alliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... Richardson, Texas (PRWEB) October 20, 2014 ... today announced that a team from Iowa State University ... * design contest. Using a Convey HC-2ex, the team’s ... than 14 times faster than the second place finisher. ... academic world embarked upon the month long challenge, using ...
(Date:10/20/2014)... 2014 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") ... orders to $5.8 million and provides a good start to Q4.  ... North America and one in the Middle ... at record levels," said Peter Bruijns , President & CEO. ... of Q3 than they have been for any complete year since ...
(Date:10/20/2014)... 2014  GenVec, Inc. (NASDAQ: GNVC ) today ... from its board of directors effective on October 24, 2014.  ... served as its chairman from June 2006 to November 2013.  ... Corporate Governance and Audit Committees of the board.  ... of dedicated service to GenVec, and its stockholders," said ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 ... Sidney Kimmel Cancer Center at Thomas Jefferson University ... , Through the Strategic Alliance Partnership program, the ... will collaborate to raise awareness of the Center’s ... and other projects. Clinicians and other health care ...
Breaking Biology Technology:Team from Iowa State Wins 2014 MemoCODE Design Contest Using Convey HC-2ex 2Team from Iowa State Wins 2014 MemoCODE Design Contest Using Convey HC-2ex 3Zola P. Horovitz To Retire From GenVec Board 2Sidney Kimmel Cancer Center at Thomas Jefferson University Partners With OncLive 2Sidney Kimmel Cancer Center at Thomas Jefferson University Partners With OncLive 3
... The following statement was issued today by the law firm of Barroway ... Notice is hereby given that a class action lawsuit was filed ... York on behalf of purchasers of the securities of Elan Corporation, plc ... 2007 and October 21, 2008, inclusive (the "Class Period"). , ...
... Dec. 11 Myngle,( http://www.myngle.com ), the global ... ICT company at the Europe Unlimited,s European Venture ... EVS is a showcase for ... and new energy entrepreneurs from all over Europe ...
... and ST. PAUL, Minn., Dec. 11 The University ... research from the,Richard M. Schulze Family Foundation. Goals for ... on the University,s strength in diabetes,research and to accelerate the ... type 1 diabetes. , ...
Cached Biology Technology:Shareholder Class Action Filed Against Elan Corporation, plc by the Law Firm of Barroway Topaz Kessler Meltzer & Check, LLP 2Myngle Best ICT Company at the European Ventures Summit 2University of Minnesota Receives $40 Million for Type 1 Diabetes Research 2University of Minnesota Receives $40 Million for Type 1 Diabetes Research 3University of Minnesota Receives $40 Million for Type 1 Diabetes Research 4
(Date:10/16/2014)... be cultivated efficiently, they are anything but sustainable: ... monoculture cultivation is becoming increasingly evident. Despite their ... and are regarded as the sole possibility of ... wrongfully, finds Bernhard Schmid, an ecology professor at ... form of agriculture and forestry. After all, a ...
(Date:10/15/2014)... our ability to assess the pandemic risk from strains ... we must not allow ourselves to become complacent that ... international consortium of scientists. , Influenza pandemics arise when ... yet to develop widespread immunity – spreads in the ... the past 100 years, the worst of which – ...
(Date:10/15/2014)... , Oct. 15, 2014 NXT-ID, Inc. (NASDAQ: ... company focused on the growing mobile commerce market releases photos and ... Times Square on Monday October 13 th . ... David Tunnel and angel investor Mr. Chad A. Verdi ... CEO of NXT-ID thanked his investors and employees "for their work ...
Breaking Biology News(10 mins):Plant communities produce greater yield than monocultures 2Plant communities produce greater yield than monocultures 3Scientists 'must not become complacent' when assessing pandemic threat from flu viruses 2Photo Release: NXT-ID Inc. Rings Opening Bell of the NASDAQ Stock Market October 13th 2Photo Release: NXT-ID Inc. Rings Opening Bell of the NASDAQ Stock Market October 13th 3
... they get rid of excess energy through the production of hydrogen. ... notice the absence of oxygen. For this, they need the messenger ... from red blood cells of humans. With colleagues at the UC ... ". Haemoglobin an old protein in a new ...
... human genome more readily in tumors than in normal ... University of Maryland School of Medicine,s Institute for Genome ... Human Genome Project, the 1,000 Genomes Project and The ... lateral gene transfer (LGT), the transmission of genetic material ...
... of the esteemed Cubist-ICAAC Award is George L. ... University of Florida, for his application of pharmacokinetic ... development. According to his nominator, Michael Dudley, Rempex ... work using pharmacokinetics/pharmacodynamics to simulate and then validate ...
Cached Biology News:When green algae run out of air 2Bacterial DNA may integrate into human genome more readily in tumor tissue 2The American Society for Microbiology honors George L. Drusano 2
XBP1 Antibody...
Recombinant Mouse MMP-9, CF...
Phosphorylcholine hapten is conjugated to BSA protein by use of p-diazonium phenylphosphorylcholine....
Human/Mouse/Rat JNK Pan Specific Affinity Purified PAb...
Biology Products: